Be Creative, Not A Cowboy: Attorneys Talk Litigation Collaboration Pitfalls
At Legalweek, a panel of partners, e‑discovery leaders and expert‑witness coordinators warned that “cowboy” attorneys—those who ignore agreed litigation playbooks—undermine collaboration. They highlighted that seamless coordination among counsel, vendors and internal stakeholders hinges on frequent communication and crystal‑clear expectations. While creativity remains valuable, the discussion stressed a clear line between innovative problem‑solving and disruptive solo actions. The panel urged firms to institutionalize playbooks and collaborative tools to keep cases on schedule and budgets in check.
Who May Sue: Patent Standing Issues and Implications for the Life Sciences Industry (Part I)
The article explains that standing is essential for filing patent lawsuits, especially for life‑sciences companies. It outlines the Federal Circuit’s framework and stresses that patentees must possess specific exclusionary, enforcement, and sublicensing rights to sue. The authors advise careful agreement...
More Big Law Leaders, 'Open to Growth,' Are Willing to Consider Mergers
Big‑law partners are increasingly signaling openness to growth through mergers, a shift highlighted by recent high‑profile talks such as Ashurst‑Perkins Coie, Hogan Lovells‑Cadwalader, and Taylor Wessing‑Winston & Strawn. Data from ALM shows a surge in lateral moves whenever merger rumors surface, amplifying market volatility. Firms...
Am Law 100: 2026 Trends, Insights & Strategies to Win
The 2026 Am Law 100 report highlights a year of disruption driven by rapid technology adoption, a wave of high‑profile law‑firm mergers, and new regulatory pressures. Firms that navigated talent wars and emerging outside‑investment interest posted strong financial results despite...
Four-Plaintiff Chicago Trial Opens Against Abbott Over Preterm Infant Formula
A fourth federal trial opened in Chicago alleging Abbott Laboratories' cow‑milk‑based infant formula triggered necrotizing enterocolitis (NEC) in premature infants. The case follows a $495 million Missouri verdict against Abbott and a $60 million Illinois verdict against Mead Johnson, both in 2024. A...